ArticleJournal of neurovirology2026
HIV-1 Nef induces astrocytes proliferation, inflammatory response, A1-like astrocytes polarization and subsequent neuronal apoptosis via NF-κB signaling pathway.
Article in Journal of neurovirology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Currently, human immunodeficiency virus-1 (HIV-1) spreads around the globe and half of HIV-1-positive individuals suffer from HIV-associated neurocognitive disorder (HAND). HIV-1 infection of astrocytes leads to neuroinflammation and neuronal injury. However, the underlying molecular mechanisms of HIV-1 negative factor (Nef)-mediated astrocytic dysfunction, remain largely unclear. In the present study, our data showed that astrocytic Nef expression facilitated astrocytes proliferation, pro-inflammatory cytokines production and A1-like astrocytes polarization. Mechanistically, Nef-activated NF-κB p65 directly bound to the promoter regions of the proliferative marker (CyclinD1), the inflammatory genes (Il-6, Ccl2, Ccl5 and Cxcl10) and the A1-specific marker (C3), and upregulated these genes expression at transcriptional levels. Conversely, NF-κB signaling inhibitor BAY11-7082 (2 μM) or RNA interference targeting of NF-κB p65 markedly mitigated astrocytes-mediated Nef neurotoxicity. Moreover, Nef-transduced astrocytes-derived conditioned media induced large amount of apoptotic HT-22 and SH-SY5Y neural cells, which was remarkably reversed in response to NF-κB inhibition. Finally, in animal models, we determined that knockdown of NF-κB p65 effectively ameliorated Nef‑induced neuroinflammation, A1-like astrocytes polarization and neuronal death. Taken together, our data suggest that Nef induces astrocytes proliferation, inflammatory response, A1-like astrocytes polarization and neuronal death in a NF-κB-dependent manner. Our findings propose that NF-κB signaling might be a desirable therapeutic target for relief of astrocytes-mediated Nef neurotoxicity.
Indexed as
Identifiers
41813910What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.